Monitoring gene and molecular changes after kidney transplant
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study checks samples from people after a kidney transplant to better understand how treatment is working at a biological (molecular) level. It may help doctors improve follow-up care and therapy over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a kidney transplant
- You are able and willing to give informed consent
- You must participate in follow-up as required by the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
This study looks at gene activity inside kidney tissue to better understand how transplanted kidneys work. Researchers will collect blood, urine, stool, and tiny pieces of kidney tissue over time to see what happens after a transplant.
This study looks at kidney biopsy samples from adult kidney transplant recipients to help improve how transplant-related problems are diagnosed and treated. If you need a biopsy for medical reasons, you may be invited to participate.
This study will collect blood samples from people having a kidney biopsy or a kidney transplant to look for biomarkers (biological signs) that can give doctors more information about kidney health. Participating may help doctors better understand and treat kidney disease in the future.
This study is looking at how genes affect kidney transplant outcomes. It asks you to give extra blood, urine, stool, and kidney tissue samples over time, so researchers can learn more about why some transplants work better than others.
This study looks at molecular changes in kidney transplants that have microvascular inflammation (a type of injury). It aims to better understand why some transplants get this inflammation, which could lead to better treatments.
Hear when a new Transplantation Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.